Scilex Holding (SCLX) Net Margin Growth (3y) (2025 - 2026)
Scilex Holding (SCLX) Net Margin Growth (3y) (2025 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 654.08 Bn | 633.32 Bn | 17.26 Bn | -204.00 |
| 2 | AbbVie | 470.80 Bn | 464.23 Bn | 12.70 Bn | 666.00 |
| 3 | Merck | 377.96 Bn | 370.82 Bn | 12.21 Bn | 3,167.00 |
| 4 | Novartis Ag | 303.49 Bn | 295.80 Bn | 11.24 Bn | -43,067.00 |
| 5 | Astrazeneca | 257.97 Bn | 253.07 Bn | 12.86 Bn | 37.00 |
| 6 | Amgen | 236.98 Bn | 222.99 Bn | 7.24 Bn | 388.00 |
| 7 | Gilead Sciences | 182.41 Bn | 179.23 Bn | 6.22 Bn | -15,026.00 |
| 8 | Pfizer | 159.49 Bn | 147.79 Bn | 10.94 Bn | -6,857.00 |
| 9 | Gsk | 106.28 Bn | 102.11 Bn | 8.24 Bn | -1,745.00 |
| 10 | Scilex Holding | 39.28 Mn | -73.51 Mn | 3.97 Mn | -128,949.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21,252.00 |
| Dec 31, 2025 | -53,409.00 |
| Sep 30, 2025 | -262,491.00 |
| Jun 30, 2025 | -64,460.00 |
| Mar 31, 2025 | -38,738.00 |